• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗菌治疗对实验性大鼠肺炎的疗效:吞噬作用受损的影响

Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

作者信息

Bakker-Woudenberg I A, de Jong-Hoenderop J Y, Michel M F

出版信息

Infect Immun. 1979 Jul;25(1):366-75. doi: 10.1128/iai.25.1.366-375.1979.

DOI:10.1128/iai.25.1.366-375.1979
PMID:478640
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC414461/
Abstract

The importance of intact host defense mechanisms for successful antimicrobial therapy was investigated in an animal model. Recovery from lobar pneumococcal pneumonia as a result of penicillin therapy was studied in normal rats and in rats treated with cobra venom factor. This factor was used to selectively suppress the phagocytosis of pneumococci as a result of complement depletion. Although complete recovery from the infection occurred in normal rats after appropriate penicillin therapy, this was not the case in cobra venom factor-treated rats. Within the limitations of this study, evidence is presented for loss of antibiotic activity as a consequence of impaired phagocytosis.

摘要

在一个动物模型中,研究了完整的宿主防御机制对于成功进行抗菌治疗的重要性。在正常大鼠和用眼镜蛇毒因子处理的大鼠中,研究了青霉素治疗导致大叶性肺炎球菌肺炎恢复的情况。该因子用于通过补体耗竭选择性抑制肺炎球菌的吞噬作用。虽然在适当的青霉素治疗后正常大鼠从感染中完全恢复,但在眼镜蛇毒因子处理的大鼠中并非如此。在本研究的局限性范围内,有证据表明吞噬作用受损会导致抗生素活性丧失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0fe/414461/dbb22bfed007/iai00187-0382-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0fe/414461/46eddbea58dc/iai00187-0381-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0fe/414461/dbb22bfed007/iai00187-0382-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0fe/414461/46eddbea58dc/iai00187-0381-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0fe/414461/dbb22bfed007/iai00187-0382-a.jpg

相似文献

1
Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.抗菌治疗对实验性大鼠肺炎的疗效:吞噬作用受损的影响
Infect Immun. 1979 Jul;25(1):366-75. doi: 10.1128/iai.25.1.366-375.1979.
2
Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis.抗菌疗法在实验性大鼠肺炎中的疗效:吞噬作用受损大鼠的抗生素治疗方案
Infect Immun. 1979 Jul;25(1):376-87. doi: 10.1128/iai.25.1.376-387.1979.
3
Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats.青霉素G连续给药与间歇给药对正常及免疫缺陷大鼠肺炎链球菌肺炎的疗效比较
Eur J Clin Microbiol. 1984 Apr;3(2):131-5. doi: 10.1007/BF02014330.
4
Protective role of complement in the development of experimental pneumococcal pneumonia in mice.补体在小鼠实验性肺炎球菌肺炎发展中的保护作用。
Chemotherapy. 1990;36(4):287-93. doi: 10.1159/000238779.
5
The role of opsonins in recovery from experimental pneumococcal pneumonia.调理素在实验性肺炎球菌肺炎恢复过程中的作用。
J Infect Dis. 1980 Aug;142(2):175-90. doi: 10.1093/infdis/142.2.175.
6
Effect of splenectomy upon the course of experimental pneumococcal bacteraemia in rats and the efficacy of penicillin therapy.脾切除术对大鼠实验性肺炎球菌菌血症病程的影响及青霉素治疗的疗效
J Infect. 1982 Jan;4(1):17-26. doi: 10.1016/s0163-4453(82)90872-6.
7
Comparative role of complement in pneumococcal and staphylococcal pneumonia.补体在肺炎球菌性肺炎和葡萄球菌性肺炎中的比较作用
Infect Immun. 1982 Sep;37(3):1270-7. doi: 10.1128/iai.37.3.1270-1277.1982.
8
Antibiotic-resistant pneumococcal pneumonia.耐抗生素肺炎球菌肺炎
S Afr Med J. 1996 Jan;86(1):28-30.
9
Treatment of pneumococcal pneumonia: the case for penicillin G.肺炎球菌肺炎的治疗:青霉素G的应用依据
Am J Med. 1999 Jul 26;107(1A):63S-68S. doi: 10.1016/s0002-9343(99)00099-6.
10
Cobra Venom Factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage.眼镜王蛇毒液因子诱导的补体耗竭通过减轻血-气屏障损伤来保护肺缺血再灌注损伤。
Sci Rep. 2018 Jul 9;8(1):10346. doi: 10.1038/s41598-018-28724-z.

引用本文的文献

1
Animal Models of .. 的动物模型
Int J Mol Sci. 2019 Aug 28;20(17):4220. doi: 10.3390/ijms20174220.
2
Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.载头孢喹肟微球制剂对肺炎克雷伯菌感染大鼠肺炎及炎症反应的保护作用
Pharm Res. 2019 Mar 28;36(5):74. doi: 10.1007/s11095-019-2614-7.
3
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections.载头孢喹肟微球制剂对实验性感染肺炎克雷伯菌感染的作用。

本文引用的文献

1
Host-parasite relationships in experimental pneumonia due to pneumococcus type III.III型肺炎球菌所致实验性肺炎中的宿主-寄生虫关系
J Exp Med. 1950 Jul 1;92(1):85-100. doi: 10.1084/jem.92.1.85.
2
The clinical implications of hypogammaglobul inemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma.慢性淋巴细胞白血病和淋巴细胞性淋巴肉瘤患者低丙种球蛋白血症的临床意义。
Ann Intern Med. 1959 Sep;51:501-16. doi: 10.7326/0003-4819-51-3-501.
3
An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery.
Drug Deliv. 2018 Nov;25(1):909-915. doi: 10.1080/10717544.2018.1461958.
4
The immune response and antibacterial therapy.免疫反应与抗菌治疗。
Med Microbiol Immunol. 2015 Apr;204(2):151-9. doi: 10.1007/s00430-014-0355-0. Epub 2014 Sep 5.
5
Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.针对低或高细菌接种量的低剂量或高剂量头孢喹肟可治愈肺炎克雷伯菌肺部感染,但对粪便菌群中的抗生素耐药性水平有不同影响。
Antimicrob Agents Chemother. 2014;58(3):1744-8. doi: 10.1128/AAC.02135-13. Epub 2014 Jan 6.
6
Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats.在成功治疗大鼠肺炎克雷伯菌感染的过程中,肠道中出现了耐药肺炎克雷伯菌。
Antimicrob Agents Chemother. 2010 Jul;54(7):2960-4. doi: 10.1128/AAC.01612-09. Epub 2010 May 10.
7
Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.接种量和马波沙星血药浓度对肺炎克雷伯菌在大鼠肺部感染模型中耐药亚群扩增的影响。
Antimicrob Agents Chemother. 2009 Nov;53(11):4740-8. doi: 10.1128/AAC.00608-09. Epub 2009 Sep 8.
8
Animal models of Streptococcus pneumoniae disease.肺炎链球菌疾病的动物模型。
Clin Microbiol Rev. 2008 Oct;21(4):666-85. doi: 10.1128/CMR.00012-08.
9
Pulmonary opsonins in Klebsiella pneumoniae pneumonia in rats.大鼠肺炎克雷伯菌肺炎中的肺调理素
Infect Immun. 1981 Aug;33(2):533-9. doi: 10.1128/iai.33.2.533-539.1981.
10
Comparative role of complement in pneumococcal and staphylococcal pneumonia.补体在肺炎球菌性肺炎和葡萄球菌性肺炎中的比较作用
Infect Immun. 1982 Sep;37(3):1270-7. doi: 10.1128/iai.37.3.1270-1277.1982.
青霉素在急性细菌感染中治疗作用的实验分析。II. 吞噬细胞在恢复过程中的作用。
J Exp Med. 1956 Apr 1;103(4):499-508. doi: 10.1084/jem.103.4.499.
4
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.霍奇金病。50例未经治疗患者的免疫学、临床及组织学特征
Ann Intern Med. 1967 Aug;67(2):291-302. doi: 10.7326/0003-4819-67-2-291.
5
Study of bactericidal and bacteriostatic antibiotics in animals with normal and suppressed immunity.正常免疫和免疫抑制动物体内杀菌和抑菌抗生素的研究。
Chemotherapia (Basel). 1968;13(2):100-7. doi: 10.1159/000220536.
6
Leukocyte function in patients with leukemia.白血病患者的白细胞功能
Cancer. 1970 Apr;25(4):835-42. doi: 10.1002/1097-0142(197004)25:4<835::aid-cncr2820250412>3.0.co;2-#.
7
Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.急性白血病患者循环白细胞与感染之间的定量关系。
Ann Intern Med. 1966 Feb;64(2):328-40. doi: 10.7326/0003-4819-64-2-328.
8
Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.中性粒细胞减少患者感染的抗生素联合用药。羧苄青霉素与头孢噻吩或卡那霉素联合用药的评估。
Cancer. 1972 Aug;30(2):573-9. doi: 10.1002/1097-0142(197208)30:2<573::aid-cncr2820300238>3.0.co;2-o.
9
Pneumococcal bacteremia in patients with neoplastic disease.肿瘤疾病患者的肺炎球菌血症
Cancer. 1974 Mar;33(3):845-9. doi: 10.1002/1097-0142(197403)33:3<845::aid-cncr2820330333>3.0.co;2-6.
10
Recent experience with bacteremia in patients presenting cancer.近期癌症患者发生菌血症的经验。
Eur J Cancer (1965). 1973 Jan;9(1):69-76. doi: 10.1016/0014-2964(73)90045-5.